{"id":"W2957828588","doi":"10.1038/s41416-019-0517-3","title":"Safety and tolerability of CFI-400945, a first-in-class, selective PLK4 inhibitor in advanced solid tumours: a phase 1 dose-escalation trial","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; University of California, Los Angeles; University of Toronto; Princess Margaret Cancer Foundation; California Institute of Regenerative Medicine; California Institute for Regenerative Medicine","keywords":"Tolerability; Medicine; Dosing; Neutropenia; Pharmacokinetics; Cmax; Adverse effect; Pharmacodynamics; Response Evaluation Criteria in Solid Tumors; Internal medicine; Pharmacology; Clinical trial; Oncology; Phases of clinical research; Toxicity","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00121196,0.0009366719,0.001229584,0.0003880121,0.0003523634,0.0008135205,0.0006383285,0.001216939,0.003371097],"category_scores_gemma":[0.000811069,0.0003373651,0.0008597072,0.0003365886,0.0005966867,0.0006336775,0.0002504992,0.002062134,0.0006186008],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001121086,"about_ca_system_score_gemma":0.001019716,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007198255,"about_ca_topic_score_gemma":0.001012247,"domain_scores_codex":[0.9995745,0.000174506,0.00002454178,0.00006488382,0.00006420892,0.00009736909],"domain_scores_gemma":[0.9995334,0.00008718616,0.000119532,0.0000408278,0.00003662958,0.0001824523],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6634231,0.04833142,0.0079733,0.0008709953,0.0009585409,0.0004572604,0.0003193047,0.006569426,0.0766885,0.000504791,0.005587165,0.1883162],"study_design_scores_gemma":[0.3830732,0.5655679,0.02670285,0.00006811602,0.0005273041,0.0007559171,0.00008247644,0.00436803,0.01287923,0.0005522722,0.005360142,0.00006274675],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958124,0.0008157548,0.0002859629,0.0001852794,0.00003486926,0.0007582986,0.000659848,0.00007840976,0.001369186],"genre_scores_gemma":[0.9952252,0.00057535,0.0004723871,0.000333646,0.00005602675,0.0006743267,0.001254271,0.00001819256,0.001390592],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003371097,"threshold_uncertainty_score":0.01127744,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.004839703614920863,"score_gpt":0.2729538451451549,"score_spread":0.268114141530234,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}